Stock exchange release
Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US
Mar 21, 2025
Stock exchange release
Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025
Mar 18, 2025
Stock exchange release
The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus
Mar 17, 2025
Stock exchange release
Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US
Mar 17, 2025
Stock exchange release
Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki
Mar 12, 2025
Company releases
Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States
Mar 06, 2025
Press releases
Nightingale Health to publish half-year report for July - December 2024 on 6 March 2025
Feb 28, 2025
Feb 27, 2025
Feb 07, 2025
Press releases
Nightingale Health and Enigma Genomics enter into collaboration to sell the Nightingale Remote Health Check in the MENA region
Jan 27, 2025
Jan 23, 2025
Dec 13, 2024